Zusammenfassung
Perioperative Gerinnungsstörungen können sich als Blutung (Hypokoagulabilität) oder als Thrombose bzw. Embolie (Hyperkoagulopathie) bemerkbar machen. Bei der Diagnose und Therapie von perioperativen Gerinnungsstörungen müssen die primäre Hämostase und das plasmatische Gerinnungssystem gesondert beachtet werden. Sowohl angeborene als auch erworbene Gerinnungsstörungen werden in diesem Kapitel vorgestellt.
Literatur
Ait-Oufella H, Maury E, Bartal C, Yitzhak A (2009) The role of thromboelastometry and recombinant factor VIIa in trauma. Curr Opin Anaesthesiol 22:281–288
Antonijevic NM, Savic NB, Perunicic J et al (2006) Salvage late plasmapheresis in a patient with pulmonary embolism caused by heparin-induced thrombocytopenia primarily resistant to danaparoid sodium and lepirudin. J Clin Apher 21:252–255
Bartal C, Yitzhak A (2009) The role of thromboelastometry and recombinant factor VIIa in trauma. Curr Opin Anaesthesiol 22:281–288
Bernstein D (2000) Effectiveness of the recombinant factor VIIa in patients with the coagulopathy of advanced child’s B and C cirrhosis. Semin Thromb Hemost 26:437–438
Bershad EM, Suarez JI (2010) Prothrombin complex concentrates for oral anticoagulant therapy-related intracranial hemorrhage: a review of the literature. Neurocrit Care 12:403–413
Bhatt DL (2007) Intensifying platelet inhibition – navigating between scylla and charybdis. N Engl J Med 357:2078–2081
Boffard KD, Riou B, Warren B et al (2005) Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double blind clinical trials. J Trauma 59:8–15
Bundesärztekammer (2009) Querschnittsleitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten – Gesamtnovelle 2008. Deutscher Ärzteverlag Köln, 4. Aufl.
Colman RW, Marder VJ, Salzman EW, Hirsh J (1993) Overview of hemostasis. In: Colman RW, Marder VJ, Salzman EW, Hirsh J (Hrsg) Hemostasis and thrombosis. Lippincott, Philadelphia, S 6–8
De Lorenzo C, Calatzis A, Welsch U, Heindl B (2006) Fibrinogen concentrate reverses dilutional coagulopathy induced by in vitro saline but not by hydroxyethyl starch 6 %. Anesth Analg 102:1194–1200
Di Nisio M, Middeldorp S, Büller HR (2005) Direct thrombin inhibitors. N Engl J Med 353:1028–1040
Douketis JD, Spyropoulos AC, Kaatz S, for the BRIDGE Investigators et al (2015) Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med 373:823–833
Federici AB, Rand JH, Bucciarelli P et al (2000) Subcommittee on von Willebrand factor: acquired von Willebrand syndrome: data from an international registry. Thromb Haemost 84:345–349
Fries D, Innerhofer P, Reif C et al (2006) The effect of fibrinogen substitution on reversal of dilutional coagulopathy: an in vitro model. Anesth Analg 102:347–351
Fries D, Martini WZ (2010) Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth 105:116–121
Giebl A, Gürtler K (2014) Neue orale Antikoagulanzien in der perioperativen Medizin. Anaesthesist 63:347–364
Görlinger K, Dirkmann D, Hanke AA et al (2011) First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 115:1179–1191
Gulba DC, Broscaru L, Amani A (2013) Elektive Eingriffe und Notfallbehandlung unter Antikoagulation – Strategien zur Optimierung bestehender Risiken. Klinikarzt 42(S1):34–39
Guth MC, Kaufner L, Kleber C, von Heymann C (2012) Behandlung der traumainduzierten Koagulopathie – Was ist die Evidenz? Anasthesiol Intensivmed Notfallmed Schmerzther 47:528–539
Hanke AA, Dellweg C, Schöchl H et al (2011) Potential of whole blood coagulation reconstitution by desmopressin and fibrinogen under conditions of hypothermia and acidosis – an in vitro study using rotation thrombelastometry. Scand J Clin Lab Invest 71:292–298
Heim MU (2009) Die neuen Querschnittleitlinien der Bundesärztekammer – Evidenzbasierte Empfehlungen für die Risiko-Nutzen-Abwägung bei der Hämotherapie. AINS Anästhesiol Intensivmed Notfallmed Schmerzther 44:186–199
Heindl B, Delorenzo C, Spannagl M (2005) Hochdosierte Fibrinogengabe zur Akuttherapie von Gerinnungsstörungen bei perioperativer Massivtransfusion. Anaesthesist 54:787–790
Himmelreich G, Riess H (1993) Pathophysiologie und Therapie der Verbrauchskoagulopathie. Klin Lab 39:25–30
Innerhofer P, Westermann I, Tauber H et al (2013) The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. Injury 44:209–216
Innerhofer P, Streif W, Kühbacher G, Fries D (2004) Monitoring der perioperativen Dilutionskoagulopathie mittels ROTEM-Analyzer – Grundlagen und klinische Beispiele. AINS Anästhesiol Intensivmed Notfallmed Schmerzther 39:739–744
James S, Akerblom A, Cannon CP et al (2009) Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial. Am Heart J 57:599–605
James AH, Manco-Johnson MJ, Yawn BP, Dietrich JE, Nichols WL (2008) Von Willebrand disease: key points from the 2008 national heart, lung, and blood institute guidelines. Obstet Gynecol 114:674–678
Keser C (2000) Thrombozytenaggregationshemmer bei Spinalanästhesie. Leserfragen Anästhesist 49:234–235
Kim TH, Kim JY, Mun HS et al (2015) Heparin bridging in warfarin anticoagulation therapy initiation could increase bleeding in non-valvular atrial fibrillation patients: a multicenter propensity-matched analysis. J Thromb Haemost 13:182–190
Kozek-Langenecker SA, Afshari A, Albaladejo P et al (2013) Management of severe perioperative bleeding: guidelines from the European society of anaesthesiology. Eur J Anaesthesiol 30:270–382
Lancé M, Stessel B, Hamulyák K, Marcus MA (2010) Alte und neue Gerinnungshemmer. Anästhesist 59:62–68
Lehoux S, Guidet B, Offenstadt G (2010) The endothelium: physiological functions and role in microcirculatory failure during severe sepsis. Intensive Care Med 36:1286–1298
Lier H, Krep H, Schöchl H (2009) Gerinnungsmanagement bei der Polytraumaversorgung. Anaesthesist 58:1010–1026
Masud F, Bostan F, Chi E et al (2009) Recombinant factor VIIa treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, efficacy, and safety outcomes. J Cardiothorac Vasc Anesth 23:28–33
Menitove JE (1991) Preparation and clinical use of plasma and plasma fractions. In: Williams WJ, Beutler E, Erslev AJ, Lichtman MA (Hrsg) Hematology. McGraw Hill, New York, S 659–673
Middelburg RA, van de Watering LM, van der Bom JG (2010) Blood transfusions: good or bad? Confounding by indication, an underestimated problem in clinical transfusion research. Transfusion 50:1181–1183
Mitra B, Mori A, Cameron PA et al (2010) Fresh frozen plasma (FFP) use during massive blood transfusion in trauma resuscitation. Injury 41:35–39
Nowak G (2009) Heparin-induced thrombocytopenia (HIT II) – a drug-associated autoimmune disease. Thromb Haemost 102:887–891
Nowak-Göttl U, Langer F, Limperger V, Mesters R, Trappe RU (2014) Bridging: Perioperatives Vorgehen bei dauerhafter oraler Antikoagulation oder Plättchenfunktionshemmung. Dtsch Med Wochenschr 139:1301–1306
Peiniger S, Nienaber U, Lefering R et al (2011) Trauma Registry of the Deutsche Gesellschaft für Unfallchirurgie. Balanced massive transfusion ratios in multiple injury patients with traumatic brain injury. Crit Care 15:R68
Pfanner G, Koscielny J, Pernerstorfer T et al (2007) Präoperative Blutungsanamnese. Anaesthesist 56:604–611
Rahe-Meyer N, Solomon C, Hanke A et al (2013) Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial. Anesthesiology 118:40–50
Rossaint R, Bouillon B, Cerny V et al (2010) Management of bleeding following major trauma: an updated European guideline. Crit Care 14:R52
Scharrer I (2005) Gerinnungsaktive Therapeutika: Antithrombin, FFP, PPSB, FXIII, rFVIIa. Haemostaseologie 25:209–212
Scherer R, Pulletz S, Ziemer S, Peters J (2001) Antithrombin (AT) – Wirkung: Experimentelle und klinische Ergebnisse. AINS Anästhesiol Intensivmed Notfallmed Schmerzther 36:628–639
Scherer R, Giebler R (2004) Perioperative Gerinnungsstörungen. AINS Anästhesiol Intensivmed Notfallmed Schmerzther 39:415–446
Schöchl H, Nienaber U, Maegele M et al (2011) Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 15:R83
Spahn D, Ganter MT (2010) Towards early individual goal-directed coagulation management in trauma patients. BJA 105:103–105
Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DB, Murphy MF (2004) Is fresh frozen plasma clinically effective? A systematic review of controlled randomized trials. Br J Haematol 126:139–152
Sucker C, Michiels JJ, Zotz RB (2009) Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies. Acta Haematol 121:177–182
Taylor FB, Emerson TE, Jordan R (1988) AT III prevents the lethal effects of Escherichia coli infusion in baboons. Circ Shock 26:227–235
Toh CH, Dennis M (2003) Current clinical practice. DIC 2002: a review of disseminated intravascular coagulation. Hematology 8:65–71
Tripodi A, Primignani M, Lemma L et al (2010) Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method. Hepatology 52:249–255
Van’t Veer C, Mann KG (2000) The regulation of the factor VII-dependent coagulation pathway: rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders. Semin Thromb Hemost 26:367–372
Waurick K, Riess H, van Aken H, Kessler P, Gogarten W, Volk T (2014) S1-Leitlinie Rückenmarksnahe Regionalanästhesien und Thromboembolieprophylaxe/antithrombotische Medikation. Anästhesiol Intensivmed 55:464–492
Weber CF, Görlinger K, Meininger D et al (2012) Point-of-care testing. A prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 117:531–547
Wiviott SD, Braunwald E, McCabe CH et al (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes (TRITON-TIMI 38). N Engl J Med 357:2001–2015
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2016 © Springer-Verlag GmbH Deutschland
About this entry
Cite this entry
Scherer, R. (2016). Anästhesie bei Patienten mit Störungen der Blutgerinnung. In: Rossaint, R., Werner, C., Zwißler, B. (eds) Die Anästhesiologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45539-5_109-1
Download citation
DOI: https://doi.org/10.1007/978-3-662-45539-5_109-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45539-5
Online ISBN: 978-3-662-45539-5
eBook Packages: Springer Referenz Medizin